Target intelligence / Profile preview

Hydroxynitrile lyase and Nitrilase (HNL/NIT)

Target
HNL/NIT
Molecular classification
Enzyme, Lyase, Hydrolase
01

Overview

Hydroxynitrile lyases (HNLs) and nitrilases are two distinct classes of enzymes that facilitate the metabolism and transformation of nitrile-containing compounds. Hydroxynitrile lyases, primarily found in plants, catalyze the reversible breakdown of cyanohydrins into hydrogen cyanide and a carbonyl compound, a process known as cyanogenesis that serves as a chemical defense mechanism [1]. Nitrilases are a broader superfamily of hydrolases that convert nitriles directly into carboxylic acids and ammonia, bypassing amide intermediates [2]. While these enzymes are not established therapeutic targets in human medicine, human homologs such as NIT1 and NIT2 have been identified and are implicated in metabolic regulation and tumor suppression pathways [3]. In the biotechnology sector, both enzyme classes are highly valued as biocatalysts for the industrial synthesis of enantiopure pharmaceutical intermediates due to their high stereoselectivity [4]. Because this entry groups two separate enzyme families with different catalytic mechanisms and biological origins, it does not represent a single, unified therapeutic target [5].

Other names
OxynitrilaseCyanohydrin lyaseNitrile aminohydrolaseNIT1NIT2Omega-amidase
02

Mechanism of action

Hydroxynitrile lyases catalyze the reversible cleavage of cyanohydrins into hydrogen cyanide and a carbonyl compound, whereas nitrilases catalyze the direct hydrolysis of nitriles to carboxylic acids and ammonia [1, 2].

03

Biological functions

CyanogenesisNitrile metabolismTumor suppressionXenobiotic detoxificationCell proliferation regulation
04

Disease associations

Cancer
05

Safety considerations

Potential for cyanide release during enzymatic activity [1]Lack of clinical validation as a therapeutic targetOff-target effects due to broad substrate specificity in industrial variants

Beyond the preview

Go deeper on Hydroxynitrile lyase and Nitrilase (HNL/NIT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxynitrile lyase and Nitrilase (HNL/NIT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call